111, Inc.
No trades
No trades
Compare with 111, Inc.
−1.73 USD
−9.24 M USD
1.75 B USD
5.09 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Jun Ling Liu
Website
Headquarters
Shanghai
Founded
2013
IPO date
Sep 12, 2018
ISIN
US68247Q2012
CUSIP
68247Q201
FIGI
BBG00LQ87SL5
Identifiers
ISIN US68247Q2012
111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
The explosive growth of E-Pharmacy in China We have already witnessed how e-commerce has taken the likes of Alibaba, JD.com, Pinduoduo, Baozun, etc registering strong growth over the past few years in China.
This company, 1 Yaowang is serving a niche market unlike the big boys - Alibaba and JD.com in this e-pharmacy space in China.
Read so
YI - Bullish Bounce - Can It Recover? RISKY..111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products di
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.









